Is this you?
Request access for Stanford Cancer Institute with your @cancer work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Stanford Cancer Institute
Unclaimed profileAcademic Network · Palo Alto, CA · ~2 sites
Intera lens
ICP 3Lift (cardio sample) 0.19Recruit soph 0.14
Quality Scorecard (1–100)
Overall81Recruit51Ops86Sponsor97Ther97
Performance (observed)
Historical trials
790
Completed
392
Terminated/Withdrawn
108
Completion rate
78%
Active now
263
Phase 2
354
Phase 3
299
Realized enrollment
297,967
First study year
1993
Years active
33
Match confidence
high
Enrollment velocity (inf)
9,029
Therapeutic
Areas
Oncology, Cancer Research, Prevention, Treatment
Specialties
Oncology; 250+ actively recruiting cancer trials; CAR-T, immunotherapy, molecular therapies
Breadth (conditions)
1,772
Languages
English + Spanish (detected)
States
CA
Recruitment (web observed)
Patient database
Y (SCIRDB - Stanford Cancer Institute Research Database)
Capability notes
NCI-Designated Comprehensive Center; 250+ actively recruiting cancer trials; Weill Cancer Hub partnership with UCSF; Sutter Health partnership
Relationships
Sponsors
National Cancer Institute (NCI); Children's Oncology Group; Gilead Sciences; Eastern Cooperative Oncology Group; SWOG Cancer Research Network; AbbVie
CROs
Acrotech Biopharma Inc.; Associazione Angela Serra per la ricerca sul cancro; Covance; Fortrea; ICON plc; IQVIA Pty Ltd
Partnerships
Academic research partnerships; NCI-designated cancer center
Owner / parent
Stanford University, Stanford Health Care, Stanford Children's Health
Funding
Academic medical center funding
Acquisitions
N
Capacity & people
Investigators
—
Coordinators
—
CEO
Steven Artandi, MD, PhD (Director)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
650.736.6170
Tech & DCT
EHR
Epic (SCIRDB/STARR integrated)
eSource
Yes
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Academic cancer center, not SMO/site network; no owned multi-site operations; focus on research/translational work rather than recruitment services; weak Intera fit—academic bureaucracy, not a recruitment-focused organization. [Validated: 2 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 0.22Liftability 0.19Overall81
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.